Literature DB >> 16685106

How we predict the etiology of acute pancreatitis.

Miguel Pérez-Mateo.   

Abstract

Although acute pancreatitis (AP) may be the consequence of numerous etiologic factors, more than 80% of the episodes are of biliary or alcoholic origin. Although the clinical picture is similar irrespective of the etiology, patients with severe episodes of acute pancreatitis require specific therapeutic maneuvers when biliary-induced while, in the case of alcoholic origin, they only need general support. As a consequence, the early estimation of the etiology is of particular interest, and older age and female sex are frequent characteristics of AP of biliary origin. Together with these factors, abnormal liver function tests have been classically used to identify biliary etiology. Their intrinsic value has grown in the era of new imaging techniques. From another perspective, the plasmatic level of carbohydrate-deficient transferrin seems to be the most accurate technique in differentiating cases of alcohol-induced acute pancreatitis from other etiologies.

Entities:  

Mesh:

Year:  2006        PMID: 16685106

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

Review 1.  New advances in acute pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2007-09       Impact factor: 3.287

2.  The Diagnostic Usefulness of Serum Total Bile Acid Concentrations in the Early Phase of Acute Pancreatitis of Varied Etiologies.

Authors:  Aleksandra Maleszka; Paulina Dumnicka; Aleksandra Matuszyk; Michał Pędziwiatr; Małgorzata Mazur-Laskowska; Mateusz Sporek; Piotr Ceranowicz; Rafał Olszanecki; Marek Kuźniewski; Beata Kuśnierz-Cabala
Journal:  Int J Mol Sci       Date:  2017-01-06       Impact factor: 5.923

3.  Elderly persons with acute pancreatitis - specifics of the clinical course of the disease.

Authors:  Dorota Koziel; Martyna Gluszek-Osuch; Edyta Suliga; Marek Zak; Stanislaw Gluszek
Journal:  Clin Interv Aging       Date:  2018-12-21       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.